GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today a multi-party collaboration for the development of Sudan...

Biotechnology company, GeoVax Labs, Inc announced this week that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company...

Yesterday, GeoVax Labs, Inc. announced the publication of its manuscript entitled “A Single-Dose of Modified Vaccinia Ankara Expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal...

GeoVax Labs, Inc. announced a collaboration with the U.S. Naval Research Laboratory (USNRL) to develop high-quality antibodies useful for detection of Lassa virus (LASV), and potentially as a treatment...

GeoVax Labs, Inc., a biotechnology company developing human vaccines, announces a major step forward in the development of a vaccine candidate for protection against Zika virus (ZIKV). Preliminary testing...